Evidence map›Paper›PMID 38841172›Full record

ArticleFrontiers in oncology2024

Case report: Sarcomatoid renal cell carcinoma masquerading as hydronephrosis.

Shicheng Chen, Zhongcong He, Mi Meng, Zhong Tian, Cheng Zhu, Ni Fu, Bo Yu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shicheng Chen *Department of Urology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.
Zhongcong He *Department of Urology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.
Mi MengDepartment of Thoracic Oncology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.
Zhong TianDepartment of Urology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.
Cheng ZhuDepartment of Urology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.
Ni FuDepartment of Urology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.
Bo YuDepartment of Urology, the Second Affiliated Hospital of ZunYi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomatoid renal cell carcinoma (SRCC), a manifestation of sarcomatoid dedifferentiation in renal cell carcinoma, is characterized by elevated invasiveness and a grim prognosis. Typically, SRCC patients present with advanced or metastatic conditions and survival rates rarely extend beyond one year. In this study, we describe a case of SRCC characterized by the patient exhibiting right flank pain without hematuria. Initially, imaging interpretations led to a diagnosis of severe hydronephrosis. Subsequently, an open right nephrectomy post-surgery confirmed the pathology of sarcomatoid renal cell carcinoma.

Indexed as

aggressive renal cell carcinomahydronephrosismisdiagnosisrare diseasesarcomatoid renal cell carcinoma

Identifiers

PMID38841172
PMCPMC11150575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.